ACP
Acuta Capital Partners Portfolio holdings
AUM
$71.6M
1-Year Return
169.78%
This Quarter Return
+16.76%
1 Year Return
+169.78%
3 Year Return
+1,553.75%
5 Year Return
+4,509.01%
10 Year Return
+155,159.98%
AUM
$234M
AUM Growth
-$43.8M
(-16%)
Cap. Flow
-$55.9M
Cap. Flow
% of AUM
-23.93%
Top 10 Holdings %
Top 10 Hldgs %
58.55%
Holding
51
New
5
Increased
8
Reduced
20
Closed
14
Top Buys
| 1 |
CYT
Cyteir Therapeutics, Inc. Common Stock
CYT
|
$5.94M |
| 2 |
Aligos Therapeutics
ALGS
|
$4.37M |
| 3 |
GH Research
GHRS
|
$3.26M |
| 4 |
SEEL
Seelos Therapeutics, Inc. Common Stock
SEEL
|
$3.01M |
| 5 |
Apellis Pharmaceuticals
APLS
|
$2.99M |
Top Sells
| 1 |
89bio
ETNB
|
$9.32M |
| 2 |
Curis
CRIS
|
$8.69M |
| 3 |
TRIL
Trillium Therapeutics Inc.
TRIL
|
$7.11M |
| 4 |
Mersana Therapeutics
MRSN
|
$5.79M |
| 5 |
Altimmune
ALT
|
$5.75M |
Sector Composition
| 1 | Healthcare | 93.7% |
| 2 | Financials | 6.2% |